Results 161 to 170 of about 5,300,619 (282)

Chemistry and pharmaceutical sciences always together

Brazilian Journal of Pharmaceutical Sciences, 2010
Elizabeth Igne Ferreira
doaj   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

Headaches in a university setting: the case of students at the Faculty of Medicine and Pharmaceutical Sciences, University of Douala. [PDF]

J Headache Pain
Magnerou AM, Massi Gams D, Mbuanguere Mouiche A, Bila Gueumekane EL, Marieya Tuikue A, Sini V, Doumbe JN, Kuate-Tegueu C, Njankouo Mapoure Y.   +8 more
europepmc   +1 more source

Progress in Pharmaceutical Sciences and Future Challenges. [PDF]

Life (Basel)
Cacabelos R.
europepmc   +1 more source

High Health Care Utilization Preceding Diagnosis With Juvenile Idiopathic Arthritis

Arthritis Care &Research, EarlyView.
Objective Although early diagnosis improves long‐term outcomes, patients with juvenile idiopathic arthritis (JIA) often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize health care utilization in the year preceding diagnosis. Methods We identified 10,021 patients with an incident diagnosis
Anna Costello, Rui Xiao, Xuemei Zhang, Jahan Jazayeri, Irit R. Rasooly, Pamela F. Weiss   +5 more
wiley   +1 more source

Developments in image-based colorimetric analysis methods and applications of CIElab color space in pharmaceutical sciences: A narrative review. [PDF]

Int J Pharm X
Marefat S, Shayanfar A, Monajjemzadeh F.
europepmc   +1 more source

Analytical Techniques in the Pharmaceutical Sciences

Advances in Delivery Science and Technology, 2016
A. Müllertz, Yvonne Perrie, Thomas Rades   +2 more
semanticscholar   +1 more source

Associations of Rheumatoid Arthritis Disease Activity With Frailty Over Five Years of Follow‐up

Arthritis Care &Research, EarlyView.
Objective To evaluate whether rheumatoid arthritis (RA) disease activity is associated with frailty both in cross‐section and longitudinally. Methods Participants within the Veterans Affairs Rheumatoid Arthritis (VARA) registry enrolled from 2003 to 2022 were included.
Courtney N. Loecker, Yangyuna Yang, Punyasha Roul, Aaron Baraff, Myra S. Schmaderer, Lani Zimmerman, Kaleb Michaud, Namrata Singh, Grant W. Cannon, Gary Kunkel, Ted R. Mikuls, Ariela R. Orkaby, Joshua F. Baker, Bryant R. England, Katherine D. Wysham   +14 more
wiley   +1 more source

Four Decades of Progress: Evaluating Saudi Arabia's Research Publications in Pharmaceutical Sciences. [PDF]

Hosp Pharm
Rohra DK, Memon I.
europepmc   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel, Fauzia Hollangel, Caroline Packee, Amita Kapoor, Brad Rovin, Nathalie Costedoat‐Chalumeau, Shivani Garg   +6 more
wiley   +1 more source